[1]
VIPLAV PRASHANT and MEERA K S 2014. SERUM FERRITIN LEVEL AND MYELOPEROXIDASE ACTIVITY IN TYPE 2 DIABETIC MALES ON ORAL HYPOGLYCEMIC AGENTS. International Journal of Pharma and Bio Sciences. 5, 4 (Dec. 2014), 373–386.